These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31593532)

  • 41. Cardiovascular changes in thyroid disorder.
    Gupta R; Varma Y; Yadav BS; Gupta R; Gupta S; Gupta N
    J Indian Med Assoc; 2006 Oct; 104(10):574, 576-8. PubMed ID: 17380822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
    Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
    Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid hormone and the cardiovascular system.
    Danzi S; Klein I
    Med Clin North Am; 2012 Mar; 96(2):257-68. PubMed ID: 22443974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiovascular consequences of thyroid diseases, their prevalence and treatment, particularly in cases with subclinical hyper- and hypothyroidism].
    Molnár I
    Orv Hetil; 2005 Oct; 146(40):2067-72. PubMed ID: 16259335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease.
    Danzi S; Klein I
    Thyroid; 2002 Jun; 12(6):467-72. PubMed ID: 12165108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Drug-induced thyroid dysfunction].
    Nishikawa M; Toyoda N; Nomura E
    Nihon Rinsho; 2012 Nov; 70(11):1958-64. PubMed ID: 23214068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of amiodarone on thyroid function.
    Harjai KJ; Licata AA
    Ann Intern Med; 1997 Jan; 126(1):63-73. PubMed ID: 8992925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Subclinical thyroid disease--should we treat, should we screen for it?].
    Trbojević B
    Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management.
    Duggal J; Singh S; Barsano CP; Arora R
    J Cardiometab Syndr; 2007; 2(3):198-206. PubMed ID: 17786084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid hormone therapy in cardiovascular disease.
    Klemperer JD; Ojamaa K; Klein I
    Prog Cardiovasc Dis; 1996; 38(4):329-36. PubMed ID: 8552790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroid function and cardiovascular events in chronic kidney disease patients.
    Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
    J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
    Serdiuk SE; Bakalov SA; Soboleva VA; Golitsin SP; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2004; 44(10):32-8. PubMed ID: 15477787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hyper- or hypothyroidism in chronic treatment with amiodarone: a diagnostic and therapeutic dilemma].
    Pineda G; Meruane J; Valenzuela MA; Bianchi C
    Rev Med Chil; 1985 May; 113(5):401-8. PubMed ID: 4095410
    [No Abstract]   [Full Text] [Related]  

  • 55. Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction.
    Yamato M; Wada K; Fujimoto M; Hosomi K; Hayashi T; Oita A; Takada M
    Eur J Clin Pharmacol; 2017 Mar; 73(3):289-296. PubMed ID: 28083650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical procedure in amiodarone-induced thyroid dysfunction].
    Różycka-Kosmalska M; Michalak R; Kosmalski M; Ptaszyński P; Wranicz JK; Zieleniewski W; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Jan; 40(235):46-52. PubMed ID: 26891437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some aspects of thyroid disease. I. Cardiovascular signs of thyroid disease.
    DRY TJ
    Tex State J Med; 1950 Nov; 46(11):802. PubMed ID: 14787935
    [No Abstract]   [Full Text] [Related]  

  • 58. [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
    Serdiuk SE; Bakalov SA; Golitsyn SP; Sitina VK; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2005; 45(1):22-7. PubMed ID: 15699935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thyroid diseases and hypertension].
    Spitzweg C; Reincke M
    Internist (Berl); 2010 May; 51(5):603-4, 606-8, 610. PubMed ID: 20358170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid status, cardiovascular risk, and mortality in older adults.
    Cappola AR; Fried LP; Arnold AM; Danese MD; Kuller LH; Burke GL; Tracy RP; Ladenson PW
    JAMA; 2006 Mar; 295(9):1033-41. PubMed ID: 16507804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.